The Wall Street Journal reporting on what appears to be a promising treatment. Citing unnamed sources.
At least in emergencies
- Food and Drug Administration is nearing a decision to authorize emergency use of antibody-rich blood plasma from recovered Covid-19 patients
- The authorization could come as early as next week
